Spring 2019 Update

Victoria is one of the world’s leading life sciences hubs, including medical technology, biotechnology and pharmaceutical industries, supported by 16 major medical research institutes, 11 teaching hospitals and nine universities.

The commercial sector employs more than 31,000 people in 1,600 firms, generates over $21.4 billion in revenue and contributes over $1.7 billion in exports to the Victorian economy.

The Victorian Government, in partnership with the sector continues to promote the State as a world-leading location to develop products, engage world leading clinicians and researchers, conduct clinical trials and manufacture high value products.

Northeast Asia is a region which is emerging as offering strategic opportunities for the Victorian biotech industry and the Victorian Government is supporting a number of initiatives over the next several months to assist Victorian companies and organisations develop connections and investigate opportunities.

In October the Victorian Government will support a delegation to Yokohama to participate in BioJapan 2019, which is Asia’s premier partnering event for the biotechnology industry. In late October, the AusBiotech Conference and Australia Biotech Invest 2019 will be held in Melbourne, where we are expecting delegates from Japan and South Korea.

With the Korean government announcing in May 2019, a Bio-Health Industry Innovation Strategy, it is timely for Victorian companies to seek partnership and collaboration opportunities with South Korean industry in areas such as clinical trials, digital health and regenerative medicine.

Participation in the AusBiotech Conference and also a proposed Victorian Government supported delegation to BioKorea in April 2020 will provide the platform for Victorian organisations to further investigate trade and partnership opportunities.

Want to know more?

For further information and to enquire about Victorian participation in BioJapan, AusBiotech or BioKorea, contact our Senior Trade Manager, Health Medical Technologies and Pharmaceuticals, Libby O’Connor by sending her an email.

Ask Us a Question or Leave a Comment

Comment Title

Comment